calendar
267 catalysts · 65 phase 2 completion · 41 phase 1 completion · 31 phase 2 initiation · 26 phase 1 initiation · 23 phase 1 2 completion · 13 phase 1 2 initiation
next 91 dayslessmore
MonWedFri
267 catalysts · 65 phase 2 completion · 41 phase 1 completion · 31 phase 2 initiation · 26 phase 1 initiation · 23 phase 1 2 completion · 13 phase 1 2 initiation
Therapy area: Oncology. Indication: Mesenchymal Tumor
Therapy area: Genito Urinary System, Immunology. Indication: Delayed Graft Function (DGF), End-Stage Kidney Disease (End-Stage Renal Disease or ESRD)
Therapy area: Oncology. Indication: Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast Cancer), Metastatic Breast Cancer, Triple-Negative Breast Cancer (TNBC)
Therapy area: Oncology. Indication: Lung Cancer
Therapy area: Oncology. Indication: Endometrial Cancer
Therapy area: Oncology. Indication: Kidney Cancer (Renal Cell Cancer), Metastatic Renal Cell Carcinoma
Therapy area: Dermatology. Indication: Unspecified Dermatological Disorders
Therapy area: Infectious Disease. Indication: Helicobacter pylori Infections
Therapy area: Dermatology. Indication: Crow Feet, Unspecified Dermatological Disorders, Wrinkles, Xerosis (Dry Skin)
Therapy area: Oncology. Indication: Soft Tissue Sarcoma
Therapy area: Oncology. Indication: Neuroblastoma
Therapy area: Immunology. Indication: Inflammation
Therapy area: Infectious Disease, Mouth and Dental Disorders. Indication: Candidiasis, Xerostomia
Therapy area: Oncology. Indication: Prostate Cancer
Therapy area: Oncology. Indication: Adenocarcinoma Of The Gastroesophageal Junction, Gastric Cancer
Therapy area: Oncology. Indication: Colorectal Cancer
Therapy area: Oncology. Indication: Small-Cell Lung Cancer